Holmquist G P
Beckman Research Institute, City of Hope Medical Center, 450 E. Duarte rd., Duarte, CA 91010, USA.
Mutat Res. 1998 May 25;400(1-2):59-68. doi: 10.1016/s0027-5107(98)00051-7.
We calculate from published levels of endogenous base lesions that our cells constantly generate and excise during base excision repair (BER) about one million lesions per day. Repair glycosylases may also non-specifically excise an additional number of undamaged bases. The resulting abasic sites are repaired daily by BER. The fidelity of polymerase-beta is 2.4x10(-5) and one must postulate additional fidelity mechanisms in the BER complex to explain the low mutation rate of resting cells. Any strategy which constitutively increases glycosylase activity to prevent endogenous lesions from entering S-phase and becoming mutations will also serve to increase the number of mutations per day caused by non-specific excision of normal undamaged bases. The best break-even strategy for reducing endogenous lesion-induced mutations is clearly not one of avid repair. Lower organisms from bacteriophage to fungi have adopted strategies to generate 0.0033 consequential mutations per cell division, no more and no less. Strategies such as down regulating glycosylase activity outside of S-phase to reduce time-dependent mutation frequency while leaving lesion replication-induced mutation frequency unchanged are discussed.
我们根据已发表的内源性碱基损伤水平计算得出,我们的细胞在碱基切除修复(BER)过程中不断产生并切除的损伤,每天约有100万个。修复糖基化酶也可能非特异性地切除额外数量的未受损碱基。由此产生的无碱基位点每天通过BER进行修复。聚合酶β的保真度为2.4×10⁻⁵,必须假定BER复合物中存在其他保真机制来解释静息细胞的低突变率。任何持续增加糖基化酶活性以防止内源性损伤进入S期并变成突变的策略,也会增加因正常未受损碱基的非特异性切除而导致的每日突变数量。减少内源性损伤诱导突变的最佳平衡策略显然不是积极修复。从噬菌体到真菌的低等生物都采用了每细胞分裂产生0.0033个后果性突变的策略,不多也不少。讨论了诸如在S期之外下调糖基化酶活性以降低时间依赖性突变频率,同时保持损伤复制诱导的突变频率不变的策略。